]

AstraZeneca's Manos Perros talks about the current challenges of treating TB

AstraZeneca\'s Manos Perros, Head of Infection iMed, talks about the current challenges of treating tuberculosis and the latest advancements in research. The TB Alliance and AstraZeneca are collaborating on numerous programs dedicated to the discovery and development of new and improved TB treatments.

Read more about AstraZeneca\'s TB research programs from the perspectives of the scientists working on the projects on their Letters from the Lab page.